Osteoporosis and Fracture History Form

This osteoporosis and fracture history form is a specialized clinical tool designed for healthcare providers who assess and manage bone health conditions. It enables systematic documentation of all recognized risk factors for osteoporosis and fragility fractures, allowing providers to calculate fracture risk scores and determine appropriate intervention strategies. The form captures the full scope of information needed for bone health evaluation, from demographic risk factors and hormonal history to lifestyle habits and previous skeletal events. By consolidating this data into a single structured intake, the form ensures that providers have the complete clinical picture necessary to guide screening, prevention, and treatment decisions.

The template collects detailed patient data across several key domains. It records patient demographics including name and date of birth, then documents a thorough fracture history covering specific fracture locations, the circumstances surrounding each fracture, and healing outcomes. The form assesses family history of osteoporosis and hip fractures in first-degree relatives. Calcium and vitamin D intake levels are evaluated through dietary and supplementation questions. A comprehensive medication review captures current prescriptions with particular attention to bone-affecting drugs such as corticosteroids, aromatase inhibitors, and anticonvulsants. Menopause status and hormonal history are recorded alongside a fall history section that identifies environmental, neurological, and medication-related fall risk factors. Previous bone density test results and dates are documented to track changes over time.

This form is essential for rheumatology practices, endocrinology clinics, orthopedic bone health programs, geriatric medicine practices, and women's health centers. It supports compliance with clinical guidelines from the National Osteoporosis Foundation, the Endocrine Society, and the American College of Rheumatology for osteoporosis screening and management. Providers use the collected data to calculate FRAX scores, determine candidacy for dual-energy X-ray absorptiometry (DXA) scanning, and evaluate appropriateness of pharmacologic therapies including bisphosphonates, denosumab, and anabolic agents. The comprehensive fall risk assessment supports development of multidisciplinary fall prevention plans, ultimately reducing fracture incidence and improving quality of life for patients with or at risk for osteoporosis.